an agreement with Apipham with sales in multiple countries. Nice. and the closing statement is also encouraging, and is reflective of what was suggested in the last earnings transcript:
“Building on our best results to date in the most recent quarter, we will continue to execute on near-term international sales opportunities, fully leveraging our world class Canadian cannabis production assets.”